Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Rani Therapeutics Holdings (RANI) Return on Invested Capital (2021 - 2023)

Historic Return on Invested Capital for Rani Therapeutics Holdings (RANI) over the last 3 years, with Q4 2023 value amounting to 1.99%.

  • Rani Therapeutics Holdings' Return on Invested Capital fell 12000.0% to 1.99% in Q4 2023 from the same period last year, while for Dec 2023 it was 1.99%, marking a year-over-year decrease of 12000.0%. This contributed to the annual value of 0.65% for FY2022, which is 99800.0% up from last year.
  • Per Rani Therapeutics Holdings' latest filing, its Return on Invested Capital stood at 1.99% for Q4 2023, which was down 12000.0% from 1.66% recorded in Q3 2023.
  • Rani Therapeutics Holdings' 5-year Return on Invested Capital high stood at 0.41% for Q4 2021, and its period low was 7.09% during Q3 2021.
  • Moreover, its 3-year median value for Return on Invested Capital was 0.79% (2022), whereas its average is 1.67%.
  • Per our database at Business Quant, Rani Therapeutics Holdings' Return on Invested Capital surged by 64500bps in 2022 and then tumbled by -12000bps in 2023.
  • Rani Therapeutics Holdings' Return on Invested Capital (Quarter) stood at 0.41% in 2021, then plummeted by -94bps to 0.79% in 2022, then plummeted by -152bps to 1.99% in 2023.
  • Its Return on Invested Capital stands at 1.99% for Q4 2023, versus 1.66% for Q3 2023 and 1.25% for Q2 2023.